Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;41(9):e133-e135.
doi: 10.2337/dc18-0999. Epub 2018 Jul 12.

Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Affiliations

Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Jakob Schöllhammer Knudsen et al. Diabetes Care. .

Similar articles

See all similar articles

Publication types

LinkOut - more resources

Feedback